10x Genomics, Inc. Net Income (Loss) Attributable to Parent in USD from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
10x Genomics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to Q3 2025.
  • 10x Genomics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$27.5M, a 23.2% increase year-over-year.
  • 10x Genomics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$76.3M, a 58.2% increase year-over-year.
  • 10x Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$183M, a 28.4% increase from 2023.
  • 10x Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$255M, a 53.7% decline from 2022.
  • 10x Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$166M, a 185% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

10x Genomics, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$76.3M -$27.5M +$8.28M +23.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 -$84.6M $34.5M +$72.4M Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-07
Q1 2025 -$157M -$34.4M +$25.6M +42.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-07
Q4 2024 -$183M -$49M -$76K -0.16% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 -$183M -$35.8M +$57.2M +61.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 -$240M -$37.9M +$24.5M +39.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-07
Q1 2024 -$264M -$59.9M -$9.2M -18.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-07
Q4 2023 -$255M -$49M -$31.7M -184% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 -$223M -$93M -$51.1M -122% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$172M -$62.4M +$2.04M +3.17% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-29
Q1 2023 -$174M -$50.7M -$8.33M -19.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-29
Q4 2022 -$166M -$17.2M +$1.23M +6.69% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 -$167M -$41.9M -$24.7M -144% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$142M -$64.5M -$53.4M -483% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$89.1M -$42.4M -$30.9M -267% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$58.2M -$18.4M +$397M +95.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 -$455M -$17.2M +$48.7M +73.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$504M -$11.1M +$29.1M +72.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$533M -$11.6M +$9.59M +45.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$543M -$416M -$408M -5725% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 -$134M -$65.8M -$56.2M -586% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$78M -$40.2M -$29.3M -269% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$48.8M -$21.1M -$17.5M -481% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$31.3M -$7.13M +$68.4M +90.6% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-27
Q3 2019 -$99.6M -$9.6M +$5.74M +37.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$105M -$10.9M -$4.96M -83.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$100M -$3.64M +$12.1M +76.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$112M -$75.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$15.3M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$5.92M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$15.7M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27

10x Genomics, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$183M +$72.5M +28.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 -$255M -$89.1M -53.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 -$166M -$108M -185% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 -$58.2M +$485M +89.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$543M -$511M -1637% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 -$31.3M +$81.2M +72.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$112M -$93.7M -500% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$18.8M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.